Molina Healthcare, Inc. (NYSE:MOH) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Shares of Molina Healthcare, Inc. (NYSE:MOHGet Rating) have been given an average recommendation of “Moderate Buy” by the fifteen research firms that are covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation, two have issued a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $344.14.

MOH has been the subject of several research reports. Wells Fargo & Company raised their price target on shares of Molina Healthcare from $307.00 to $345.00 and gave the stock an “underweight” rating in a report on Friday, August 26th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Molina Healthcare from $311.00 to $315.00 in a research note on Monday, August 1st. Loop Capital initiated coverage on shares of Molina Healthcare in a research note on Thursday, June 16th. They issued a “hold” rating and a $310.00 target price for the company. Credit Suisse Group set a $321.00 target price on shares of Molina Healthcare in a research note on Tuesday, July 19th. Finally, Bank of America cut shares of Molina Healthcare from a “buy” rating to an “underperform” rating and reduced their target price for the company from $355.00 to $335.00 in a research note on Thursday, May 26th.

Insider Transactions at Molina Healthcare

In related news, insider Jeff D. Barlow sold 90 shares of the company’s stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $333.01, for a total transaction of $29,970.90. Following the completion of the transaction, the insider now directly owns 81,146 shares in the company, valued at approximately $27,022,429.46. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Jeff D. Barlow sold 90 shares of the company’s stock in a transaction on Tuesday, August 9th. The shares were sold at an average price of $333.01, for a total transaction of $29,970.90. Following the completion of the transaction, the insider now directly owns 81,146 shares in the company, valued at approximately $27,022,429.46. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Joseph M. Zubretsky sold 30,600 shares of the company’s stock in a transaction on Monday, September 19th. The shares were sold at an average price of $340.74, for a total transaction of $10,426,644.00. Following the transaction, the chief executive officer now owns 255,157 shares of the company’s stock, valued at $86,942,196.18. The disclosure for this sale can be found here. Over the last three months, insiders sold 115,332 shares of company stock worth $38,860,346. 1.49% of the stock is owned by insiders.

Hedge Funds Weigh In On Molina Healthcare

Several large investors have recently bought and sold shares of the stock. Private Trust Co. NA acquired a new position in Molina Healthcare during the 2nd quarter valued at $25,000. First National Bank of Omaha raised its stake in shares of Molina Healthcare by 26.7% in the 2nd quarter. First National Bank of Omaha now owns 4,596 shares of the company’s stock valued at $1,285,000 after buying an additional 969 shares in the last quarter. Verition Fund Management LLC acquired a new position in shares of Molina Healthcare in the 2nd quarter valued at $1,695,000. Prelude Capital Management LLC raised its stake in shares of Molina Healthcare by 205.7% in the 2nd quarter. Prelude Capital Management LLC now owns 2,033 shares of the company’s stock valued at $568,000 after buying an additional 1,368 shares in the last quarter. Finally, ExodusPoint Capital Management LP raised its stake in shares of Molina Healthcare by 126.8% in the 2nd quarter. ExodusPoint Capital Management LP now owns 14,758 shares of the company’s stock valued at $4,126,000 after buying an additional 8,250 shares in the last quarter. 95.40% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Stock Performance

Molina Healthcare stock opened at $329.51 on Friday. The firm’s 50 day simple moving average is $328.46 and its 200-day simple moving average is $313.61. The company has a market cap of $19.14 billion, a P/E ratio of 25.66, a price-to-earnings-growth ratio of 1.14 and a beta of 0.83. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.43 and a quick ratio of 1.43. Molina Healthcare has a fifty-two week low of $249.78 and a fifty-two week high of $361.25.

Molina Healthcare (NYSE:MOHGet Rating) last released its earnings results on Wednesday, July 27th. The company reported $4.55 earnings per share for the quarter, topping the consensus estimate of $4.34 by $0.21. The business had revenue of $8.05 billion for the quarter, compared to the consensus estimate of $7.69 billion. Molina Healthcare had a net margin of 2.48% and a return on equity of 32.97%. The firm’s quarterly revenue was up 18.4% compared to the same quarter last year. During the same period last year, the firm posted $3.40 earnings per share. As a group, equities research analysts predict that Molina Healthcare will post 17.66 EPS for the current year.

Molina Healthcare Company Profile

(Get Rating)

Molina Healthcare, Inc provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states.

Further Reading

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.